Transdermal drug delivery systems in cancer therapy: advances, challenges, and future perspectives.

Arghidash F, Judaki AA, Nejad MMS, Nazari E, Rezaei-Tavirani M

Open source

DOI
10.1007/s00228-026-04086-8
Published
2026 Jun 1
Container
European journal of clinical pharmacology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00228-026-04086-8,
  title = {Transdermal drug delivery systems in cancer therapy: advances, challenges, and future perspectives.},
  author = {Arghidash F and Judaki AA and Nejad MMS and Nazari E and Rezaei-Tavirani M},
  year = {2026},
  journal = {European journal of clinical pharmacology},
  doi = {10.1007/s00228-026-04086-8},
  url = {https://doi.org/10.1007/s00228-026-04086-8}
}

RIS

TY  - JOUR
TI  - Transdermal drug delivery systems in cancer therapy: advances, challenges, and future perspectives.
AU  - Arghidash F
AU  - Judaki AA
AU  - Nejad MMS
AU  - Nazari E
AU  - Rezaei-Tavirani M
PY  - 2026
JO  - European journal of clinical pharmacology
DO  - 10.1007/s00228-026-04086-8
UR  - https://doi.org/10.1007/s00228-026-04086-8
ER  - 

APA

F, A., AA, J., MMS, N., E, N., & M, R. (2026). Transdermal drug delivery systems in cancer therapy: advances, challenges, and future perspectives.. European journal of clinical pharmacology. https://doi.org/10.1007/s00228-026-04086-8

Source records